These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25218638)

  • 1. Bladder cancers arise from distinct urothelial sub-populations.
    Van Batavia J; Yamany T; Molotkov A; Dan H; Mansukhani M; Batourina E; Schneider K; Oyon D; Dunlop M; Wu XR; Cordon-Cardo C; Mendelsohn C
    Nat Cell Biol; 2014 Oct; 16(10):982-91, 1-5. PubMed ID: 25218638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.
    Masuda N; Murakami K; Kita Y; Hamada A; Kamada M; Teramoto Y; Sakatani T; Matsumoto K; Sano T; Saito R; Okuno Y; Ogawa O; Kobayashi T
    Am J Pathol; 2020 Aug; 190(8):1752-1762. PubMed ID: 32339497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Words of wisdom. Bladder cancers arise from distinct urothelial sub-populations.
    Bryan RT; Ward DG
    Eur Urol; 2015 Mar; 67(3):590-1. PubMed ID: 25760413
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.
    Shin K; Lim A; Odegaard JI; Honeycutt JD; Kawano S; Hsieh MH; Beachy PA
    Nat Cell Biol; 2014 May; 16(5):469-78. PubMed ID: 24747439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.
    Palmeira C; Lameiras C; Amaro T; Lima L; Koch A; Lopes C; Oliveira PA; Santos L
    Urol Oncol; 2011; 29(2):205-11. PubMed ID: 19854077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder.
    Murata S; Iseki M; Kinjo M; Matsuzaki O; Moriuchi A; Ohtani H; Sakurai T; Satake T; Tsuzuki T
    Am J Clin Pathol; 2010 Dec; 134(6):862-72. PubMed ID: 21088148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W; Herrera GA
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.
    Conconi D; Panzeri E; Redaelli S; Bovo G; Volante M; Viganò P; Strada G; Dalprà L; Bentivegna A
    BMC Res Notes; 2012 Oct; 5():607. PubMed ID: 23114535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
    Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
    Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
    Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
    J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
    Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
    Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
    Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
    Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
    Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
    Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma.
    Boyaci C; Behzatoğlu K
    Turk Patoloji Derg; 2019; 35(1):22-27. PubMed ID: 30035295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time- and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice.
    Tamano S; Hagiwara A; Suzuki E; Okada M; Shirai T; Fukushima S
    Jpn J Cancer Res; 1991 Jun; 82(6):650-6. PubMed ID: 1906851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Min W; Lee CC; Salim EI; Wanibuchi H; Sukata T; Fukushima S
    Cancer Lett; 1999 Jan; 135(2):137-44. PubMed ID: 10096421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.